The following table, summarizes significant adverse events occurring in 316 patients treated with the leucovorin/5-fluorouracil combinations compared against 70 patients treated with 5-fluorouracil alone for advanced colorectal carcinoma. These data are taken from the Mayo/NCCTG large multicentre prospective trial evaluating the efficacy and safety of the combination regimen. (See Table 2.)

View ADR Reporting Link